IRVINE, Calif., March 22, 2012 /CNW/ - Avrio Biopharmaceuticals, LLC, announced the appointment of William P. Botha as President. Mr. Botha brings a wealth of knowledge, business experience and leadership stemming from over 24 years of direct experience in manufacturing and the pharmaceutical, biotech, and medical device industries.
"I am very excited to welcome William to the Avrio team. William brings an important combination of strategic, financial, and operational experience. I am certain that he will play a critical role in the success of our organization," said Assad J. Kazeminy, Ph.D., CEO and Founder of Avrio.
Mr. Botha has a proven track record exhibiting core strengths in GMP, GDP, bulk production, purification, filling, lyophilization, labeling, device assembly, packaging, fractionation, perfusion, and field inventory management. Before joining Avrio, Mr. Botha built an outstanding track record while serving as the Senior Director of Operational Excellence at Genzyme Corporation and prior to that, as a Plant Manager and Director of Pharmaceutical Manufacturing at Baxter Healthcare. He is an internationally recognized figure in the biopharmaceutical operations space as a result of his 20 plus years of management. His expertise lies in lean leadership and crafting a culture of continuous improvement to bring about fundamental business change through elegant strategies, robust organizational structures, systems, and focused behaviors. His recognized leadership skills, depth of knowledge of lean manufacturing, and commitment to providing quality services to his customers make him perfectly suited to contribute to the future success of Avrio for many years ahead.
To learn more about how Avrio is growing to meet client requirements for high quality manufacturing and development services, visit www.avriobiopharma.com or call: 866-98-AVRIO (866-982-8746).
About Avrio Biopharmaceuticals, LLC
Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).
SOURCE Avrio Biopharmaceuticals, LLC
For further information:
Katee Fry, Marketing Manager for Avrio Biopharmaceuticals, LLC, +1-866-98-AVRIO (+1-866-982-8746), [email protected]